Vilon (Lys-Glu) appears to modulate immune responses by enhancing the differentiation of T-cell precursors into CD4(+) T-helper and CD8(+) cytotoxic T cells, potentially through the activation of specific receptors involved in lymphocyte maturation, although the precise receptors and signaling pathways remain to be fully elucidated. Additionally, Vilon influences gene expression in the heart, affecting pathways related to cellular stress response and apoptosis, as indicated by its modulation of gene expression profiles in treated mice. Its effects on glucose absorption suggest involvement in transport mechanisms, possibly through modulation of GLUT transporters, but the exact signaling pathways are not clearly defined.